UK rolls out AstraZeneca-Oxford vaccine

An 82-year-old man has become the first person in Britain to receive the COVID-19 vaccine developed by AstraZeneca and Oxford University.

That development on Monday came as officials reported more than 50,000 new cases for the sixth day in a row following the emergence in the country of a new strain of the virus.

Last month, Britain approved another vaccine developed by Pfizer and BioNTech.

The AstraZeneca-Oxford shot can be stored at the temperatures of normal refrigerators, making it easier to distribute and store than the Pfizer vaccine.

British officials will set up more than 1,000 vaccination sites across the country and urge tens of millions of people to get vaccinated over the next three months.